Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock investors purchased 14,617 call options on the stock. This represents an increase of 230% compared to the typical daily volume of 4,428 call options.
Institutional Investors Weigh In On Aurora Cannabis
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Virtu Financial LLC bought a new position in Aurora Cannabis during the 1st quarter valued at approximately $727,000. TD Asset Management Inc bought a new position in Aurora Cannabis during the 2nd quarter valued at approximately $255,000. Headlands Technologies LLC bought a new position in Aurora Cannabis during the 1st quarter valued at approximately $166,000. Mackenzie Financial Corp bought a new position in Aurora Cannabis during the 2nd quarter valued at approximately $113,000. Finally, Concurrent Investment Advisors LLC bought a new position in Aurora Cannabis during the 1st quarter valued at approximately $90,000. Institutional investors own 47.63% of the company's stock.
Aurora Cannabis Stock Performance
Shares of NASDAQ ACB traded down $0.19 during mid-day trading on Wednesday, hitting $5.91. The company had a trading volume of 2,099,954 shares, compared to its average volume of 3,185,764. The company has a market capitalization of $322.37 million, a price-to-earnings ratio of -4.36 and a beta of 1.86. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The company has a current ratio of 3.76, a quick ratio of 2.03 and a debt-to-equity ratio of 0.08. The stock's 50-day moving average price is $5.85 and its 200-day moving average price is $6.05.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.24. Aurora Cannabis had a negative return on equity of 7.00% and a negative net margin of 14.46%. The business had revenue of $67.27 million during the quarter, compared to analysts' expectations of $55.98 million. On average, sell-side analysts forecast that Aurora Cannabis will post -0.37 earnings per share for the current year.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
